GOLD ROCK HOLDINGS, INC. financials

GRHI CIK 0000894501

Source: EDGAR filings · Built 2026-06-19T02:27:22Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Working Capital -2.31K 175.21K -9.79K -401.89K -8.59K -102.20K
Gross Margin 100.00% 100.00%
Net Margin -85.37% -173.79%
Return on Equity (ROE) 7816.62% -137.37% 2372.46% 108.03% 1072.15% 43.15%
Return on Assets (ROA) -346.43% -94.91% -215102.78% -33814.80% -5414.35% -2450.00%
Current Ratio 0.98× 3.23× 0.01× 0.00× 0.17× 0.02×
Cash Conversion Ratio 0.32× 0.90× 0.10× 0.09× 0.50× 0.06×
Accruals Ratio -2.36× -0.10× -1941.90× -306.77× -27.11× -23.11×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Revenues 211.50K 138.50K
Gross Profit 211.50K 138.50K
Operating Expenses 392.06K 379.19K 232.31K 434.18K 92.04K 44.10K
Net Income (Loss) Attributable to Parent -180.56K -240.69K -232.31K -434.18K -92.04K -44.10K
Earnings Per Share, Basic $0.00 $0.00 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Basic 238.16M 237.29M 97.26M 87.46M
Earnings Per Share, Diluted $0.00 $0.00 $0.00 $0.00
Weighted Average Number of Shares Outstanding, Diluted 238.16M 237.29M 97.26M 87.46M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Cash and Cash Equivalents, at Carrying Value 52.12K 209.61K 108 1.28K 1.70K 1.70K
Assets, Current 152.12K 253.61K 108 1.28K 1.70K 1.80K
Assets 52.12K 253.61K 108 1.28K 1.70K 1.80K
Liabilities, Current 154.43K 78.40K 9.90K 403.18K 10.29K 104.00K
Liabilities 154.43K 78.40K 9.90K 403.18K 10.29K 104.00K
Stockholders' Equity Attributable to Parent -2.31K 175.21K -9.79K -401.89K -8.59K -102.20K
Common Stock, Shares, Outstanding 238.22M 238.14M 231.05M 87.48M 87.38M 47.23M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2021
Net Cash Provided by (Used in) Operating Activities -57.49K -216.19K -22.59K -40.29K -45.96K -2.50K
Net Cash Provided by (Used in) Financing Activities 425.70K 21.41K 39.88K 45.96K 2.50K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GRHI CIK 0000894501), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

IONS

IONIS PHARMACEUTICALS, INC.

SERA

SERA PROGNOSTICS, INC.

BL

BlackLine, Inc.